Avalyn Pharma Inc. Common Stock News

Latest Avalyn Pharma Inc. Common Stock Stock News & AVLN Headlines

Avalyn Pharma Inc. (AVLN) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript

4 days ago | seekingalpha.com

Avalyn to Present at Upcoming Investor Conferences

13 days ago | globenewswire.com

Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated “Moderate Buy” by Wall Street Analysts

a month ago | defenseworld.net

Avalyn Publishes Phase 1 Data Highlighting AP02's Lung-Targeted Delivery and Encouraging Safety Profile

2 months ago | globenewswire.com

Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors

2 months ago | globenewswire.com

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

2 months ago | globenewswire.com

Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026

3 months ago | globenewswire.com

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

3 months ago | globenewswire.com

Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis

5 months ago | globenewswire.com

Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead

5 months ago | marketbeat.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

AVLN

Avalyn Pharma Inc. Common Stock

$ 30.28

-1.01%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Avalyn Pharma Inc. Common Stock News

Latest Avalyn Pharma Inc. Common Stock Stock News & AVLN Headlines

Download App

People Also Watch

Explore our Tools